Latest Updates

We are thrilled to announce a major funding milestone that will support our upcoming 5-day human bed-rest trials. This research will investigate the molecular adaptation pathways of skeletal muscle disuse atrophy and evaluate targeted nutritional countermeasures to preserve mobility in aging populations. The project represents a significant collaborative effort across clinical and proteomic research divisions. Over the course of the 5-day immobilization period, participants will undergo rigorous physiological monitoring, including daily muscle biopsies, bilateral ultrasound imaging, and continuous metabolic assessment. By utilizing state-of-the-art deuterium stable isotope tracers, our team will be able to track muscle protein fractional synthetic rates at an extremely high resolution, pinpointing exactly how cellular pathways adapt to sudden disuse. Ultimately, this study aims to validate a novel cocktail of nutritional countermeasures designed to mitigate muscle wasting. The insights gained from this trial could revolutionize clinical care protocols for bedridden patients, post-surgical recovery, and long-duration spaceflight. We extend our deepest gratitude to our clinical partners and funding agencies for making this work possible.